Electrochemical treatment of lung cancer
Journal Article
·
· Bioelectromagnetics
- China-Japan Friendship Hospital, Beijing (China). Dept. of Thoracic Surgery
A pilot study of electrochemical treatment (ECT) as a therapy for 386 patients with nonsmall cell lung cancer was undertaken. There were 103 stage 2 cases, 89 stage 3a cases, 122 stage 3b cases, and 72 stage 4 cases. Two ECT methods were used. For peripherally located lung cancer, platinum electrodes were inserted transcutaneously into the tumor under x-ray or CT guidance. For central type lung cancer or for those inoperable during thoracotomy, electrodes were inserted intraoperatively directly into the cancer. Voltage was 6--8 V, current was 40--100 mA, and electric charge was 100 coulombs per cm of tumor diameter. The number of electrodes was determined from the size of cancer mass, because the diameter of effective area around each electrode is approximately 3 cm. The short-term (6 months after ECT) results of the 386 lung cancer cases were: complete response (CR), 25.6% (99/386); partial response (PR), 46.4% (179/386); no change (NC), 15.3% (59/386); and progressive disease (PD), 12.7% (49/386). The total effective rate (CR + PR) was 72% (278/386). The 1, 3, and 5 year overall survival rates were 86.3% (333/386), 58.8% (227/386), and 29.5% (114/386), respectively. The main complication was traumatic pneumothorax, with an incidence rate of 14.8% (57/386). These clinical results show that ECT is simple, safe, effective, and minimally traumatic. ECT provides an alternative method for treating lung cancers that are conventionally inoperable, that are not responsive to chemotherapy or radiotherapy, or that cannot be resected after thoracotomy. Long-term survival rates suggest that ECT warrants further investigation.
- OSTI ID:
- 435410
- Journal Information:
- Bioelectromagnetics, Journal Name: Bioelectromagnetics Journal Issue: 1 Vol. 18; ISSN BLCTDO; ISSN 0197-8462
- Country of Publication:
- United States
- Language:
- English
Similar Records
Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
Implantation and Stability of Metallic Fiducials Within Pulmonary Lesions
Electrochemical treatment of mouse and rat fibrosarcomas with direct current
Journal Article
·
Wed Nov 30 23:00:00 EST 2005
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:20788235
Implantation and Stability of Metallic Fiducials Within Pulmonary Lesions
Journal Article
·
Thu Nov 01 00:00:00 EDT 2007
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:21039581
Electrochemical treatment of mouse and rat fibrosarcomas with direct current
Journal Article
·
Fri Feb 28 23:00:00 EST 1997
· Bioelectromagnetics
·
OSTI ID:435411